干燥综合征相关的血栓性血小板减少性紫癜的临床分析
被引量:1
摘要
血栓性血小板减少性紫癜(TTP)是累及多器官系统的血栓性微血管病,先天性TTP是由于血管性血友病因子裂解蛋白酶(vWF-CP)基因杂合子或纯合子的复合突变,为常染色体隐性遗传,呈复发趋向。获得性TTP包括特发性(占33%-57%)和继发性(占43%-66%)[1],后者常继发于自身免疫性疾病、妊娠、感染、药物、恶性肿瘤或造血干细胞移植等。
出处
《江苏医药》
CAS
北大核心
2014年第17期2086-2088,共3页
Jiangsu Medical Journal
基金
江苏省中医药局科技项目(L213219)
参考文献10
-
1王学文.获得性血栓性血小板减少性紫癜免疫治疗的进展[J].中国微循环,2007,11(3):209-212. 被引量:2
-
2Toumeh A,Josh N,Narwal R,et al.Refractory thrombotic thrombocytopenic purpura associated with primary Sjgren′s syndrome treated with Rituximab:a case report[J].Am J Ther,2014,21(2):e56-e60.
-
3Schattner A,Friedman J,Klepfish A,et al.Thrombotic thrombocytopenic purpura as an initial presentation of primary Sjgren′s syndrome[J].Clin Rheumatol,2002,21(1):57-59.
-
4Abe H,Tsuboi N,Yukawa S,et al.Thrombotic thrombocytopenic purpura complicating Sjgren′s syndrome with crescentic glomerulonephritis and membranous nephritis[J].Mod Rheumatol,2004,14(2):174-178.
-
5Koga T,Yamasaki S,Nakamura H,et al.Renal thrombotic microangiopathies/thrombotic thrombocytopenic purpura in a patient with primary Sjgren′s syndrome complicated with IgM monoclonal gammopathy of undetermined significance[J].Rheumatol Int,2013,33(1):227-230.
-
6Lin TY,Chang CC,Chang CC,et al.Cyclophosphamiderescued plasmapheresis-unresponsive secondary thrombotic thrombocytopenic purpura caused by Sjgren′s syndrome[J].Arch Med Sci,2012,8(5):934-938.
-
7Yamashita H,Takahashi Y,Kaneko H,et al.Thrombotic thrombocytopenic purpura with an autoantibody to ADAMTS13complicating Sjgren′s syndrome:two cases and a literature review[J].Mod Rheumatol,2013,23(2):365-373.
-
8Hovinga JA,Vesely SK,Terrell DR,et al.Survival and relapse in patients with thrombotic thrombocytopenic purpura[J].Blood,2010,115(8):1500-1511.
-
9Jasti S,Coyle T,Gentile T,et al.Rituximab as an adjunct to plasma exchange in TTP:a report of 12cases and review of literature[J].J Clin Apher,2008,23(5):151-156.
-
10Franchini M,Veneri D,Lippi G,et al.The efficacy of Rituximab in the treatment of inhibitor-associated hemostatic disorders[J].Thromb Haemost,2006,96(2):119-125.
二级参考文献20
-
1藤村吉博.TTPと HUS[J].医学のぁゅみ,2003,206(1):101-104.
-
2Vesely SK,George JN,Lammle B,et al.ADAMTS-13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:related to presenting features and clinical outcomes in a prospective cohort of 142 patients[J].Blood,2003,102(1):60 ~68
-
3Kremer Hovinga JA,Studt JD,Alberio L,et al.vonWillebrand factor-Cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies:The Swiss experience[J].Semin Hematol,2004,41 (1):75 ~ 82
-
4Gutterman LA,Kloster B,Tsai HM.Rituximab therapy for refractory thrombotic thrombocytopenic purpura[J].Blood Cells Mod Dis,2000,28(3):385 ~391
-
5Tsai HM,Shulman K.Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura[J].Eur J Haematol,2003,70 (3):183 ~ 185
-
6Sallah S,Husain A,Wan JY,et al.Rituximab in patients with refractory thrombotic thrombocytopenic purpura[J].J Thromb Haemost,2004,2:834 ~ 836
-
7Reddy PS,Deauna-Limayo D,Cook JD,et al.Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura[J].Ann Hematol,2005,84 (2):232 ~ 235
-
8Fakhouri F,Vernant JP,Veyradier A,et al.Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura:a study of 11 cases[J].Blood,2005,106(6):1932 ~ 1937
-
9Allan DS,Kovacs MJ,Clark WF.Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy[J].Haematologica,2001,86 (8):844 ~ 850
-
10Dervenoulas J,Tsirigotis P,Bollas G,et al.Effeicacy of intravascular immunoglobulin in the treatment of thrombotic thrombocytopenic purpura[J].A study of 44 cases,2001,105(4):204 ~205
同被引文献11
-
1房丽华,赵岩,曾小峰.儿童原发性干燥综合征的临床特点[J].中华儿科杂志,2004,42(8):568-570. 被引量:13
-
2颜淑敏,曾小峰.原发性干燥综合征诊治进展[J].实用医院临床杂志,2007,4(3):6-8. 被引量:23
-
3翟小琳.40例干燥综合征临床分析[J].中国医疗前沿,2009,4(1):62-62. 被引量:5
-
4颜淑敏,张文,李梦涛,赵岩,曾小峰,张奉春,董怡.原发性干燥综合征573例临床分析[J].中华风湿病学杂志,2010,14(4):223-227. 被引量:62
-
5胡银秀,陆亚华,郑善翠.120例原发性干燥综合征临床特点分析[J].临床荟萃,2011,26(8):704-706. 被引量:10
-
6王静,涂亚庭,黄长征,陈思远,王玉珏,李娅,夏颖,陶娟.Waldenstrm高γ球蛋白血症型紫癜并发干燥综合征[J].临床皮肤科杂志,2012,41(5):296-298. 被引量:9
-
7姚朝琼,吴建红,张卫华.132例干燥综合征住院患者首发表现和起病特点的回顾分析[J].中国医药指南,2012,10(21):449-450. 被引量:6
-
8王心声,乔娜,付萍.原发性干燥综合征59例皮肤黏膜表现分析[J].临床皮肤科杂志,2012,41(12):716-718. 被引量:3
-
9张乃峥,曾庆馀,张凤山,陈纪邦,施全胜,要庆平,赵岩,曾学军,董怡.中国风湿性疾病流行情况的调查研究[J].中华风湿病学杂志,1997,1(A01):34-38. 被引量:126
-
10王景,宣磊,董振华.儿童原发性干燥综合征57例临床分析[J].中国临床医生杂志,2018,46(2):224-226. 被引量:11
二级引证文献2
-
1张科,何雪春,陈超,韩燕英.原发性干燥综合征相关间质性肺疾病的发生率及危险因素分析[J].实用临床医药杂志,2021,25(18):10-14. 被引量:5
-
2韩畅,戴莉萍,田红军,陈新鹏,肖剑伟.免疫吸附联合糖皮质激素、免疫抑制剂治疗以高球蛋白血症性紫癜为主要表现的干燥综合征一例[J].中国麻风皮肤病杂志,2023,39(8):608-610.
-
1陈德臻,尹良红,李云逸.血栓性血小板减少性紫癜诊治新进展[J].国际医药卫生导报,2015,21(13):1822-1826. 被引量:1
-
2王倩,韩悦.ADAMTS13的结构、功能及其与TTP诊疗的关系[J].中国实验血液学杂志,2014,22(4):1157-1161. 被引量:5
-
3蒋玉洁,曾勉,许元文,何婉媚,陈瑞滔,李斌.慢性阻塞性肺疾病患者血浆ADAMTS-13变化及其与血栓前状态关系[J].中山大学学报(医学科学版),2014,35(2):256-260. 被引量:7
-
4张文娟,韩悦,苏健,白霞,金松,徐明珠,孙爱宁,阮长耿,吴德沛.造血干细胞移植后ADAMTS13缺失的血栓性血小板减少性紫癜一例报告并文献复习[J].中华血液学杂志,2014,35(1):69-70. 被引量:1
-
5王兆钺.血管性血友病因子裂解蛋白酶在血栓性血小板减少性紫癜的意义[J].国外医学(内科学分册),2003,30(11):469-472. 被引量:2
-
6曾勉,陈瑞滔,陈燕珠.血栓栓塞性疾病与ADAMTS-13相关性的研究进展[J].国际呼吸杂志,2014,34(24):1875-1878.
-
7王辉,李小彬.成功治疗血栓性血小板减少性紫癜合并肺孢子菌肺炎一例[J].中华急诊医学杂志,2017,26(1):115-116. 被引量:1
-
8孙彩凤,刘国强,赵霞,韩芳,徐敏,邢健,刘娟.ADAMTS13在血栓前疾病状态中的水平及其相关因素分析[J].中国实验血液学杂志,2016,24(4):1125-1131. 被引量:3
-
9潘玉夏,尚银涛,王兴哲,王茜,温树鹏,杨琳.血管性血友病因子裂解蛋白酶活性及抑制物检测在获得性血栓性血小板减少性紫癜中的应用[J].中国临床医生杂志,2015,43(7):36-38. 被引量:3
-
10刘芳,王兆钺.血管性血友病因子裂解蛋白酶活性的检测方法及评估[J].国外医学(输血及血液学分册),2005,28(6):519-522. 被引量:1